Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis

PURPOSE: For high-risk prostate cancer (HR-PCa) in men with a life expectancy of at least 10 years, the National Comprehensive Cancer Network recommends radiation therapy (RT) plus androgen deprivation therapy (ADT) with category 1 evidence or radical prostatectomy (RP) as an acceptable initial ther...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Adv Radiat Oncol
Main Authors: Markovina, Stephanie, Meeks, Marshall W., Badiyan, Shahed, Vetter, Joel, Gay, Hiram A., Paradis, Alethea, Michalski, Jeff, Sandhu, Gurdarshan
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2017
Teme:
Prostate Cancer
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000029/
https://ncbi.nlm.nih.gov/pubmed/29904744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2017.12.001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki